Jörn Hilfrich Selected Research

Jörn Hilfrich Research Topics

Disease

33	Breast Neoplasms (Breast Cancer) 11/2019 - 10/2002
20	Neoplasms (Cancer) 11/2019 - 10/2002
5	Pathologic Complete Response 01/2018 - 04/2010
2	Inflammatory Breast Neoplasms 11/2019 - 01/2010
2	Triple Negative Breast Neoplasms 01/2018 - 06/2014
2	Carcinoma (Carcinomatosis) 10/2017 - 01/2008
2	Circulating Neoplastic Cells 09/2017 - 05/2010
2	Diarrhea 07/2015 - 04/2010
2	Infections 07/2015 - 07/2013
2	Thrombocytopenia (Thrombopenia) 06/2014 - 07/2013
2	Neutropenia 06/2014 - 07/2013
2	Exanthema (Rash) 07/2013 - 02/2012
1	Sepsis (Septicemia) 03/2016
1	Heart Failure 03/2016
1	Lobular Carcinoma 02/2014
1	Inflammation (Inflammations) 07/2013
1	Hand-Foot Syndrome 04/2010
1	Conjunctivitis 04/2010
1	Cardiotoxicity 04/2010
1	Edema (Dropsy) 04/2010
1	Febrile Neutropenia 04/2010
1	Ovarian Epithelial Carcinoma 09/2009
1	Ovarian Neoplasms (Ovarian Cancer) 09/2009
1	Ascites 09/2009
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Disease Progression 01/2005

Drug/Important Bio-Agent (IBA)

13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016 - 10/2002
12	Docetaxel (Taxotere)FDA Link 08/2013 - 10/2002
9	taxaneIBA 01/2018 - 01/2005
8	Hormones (Hormone)IBA 01/2016 - 04/2005
8	Trastuzumab (Herceptin)FDA Link 07/2015 - 04/2010
8	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2013 - 10/2002
7	AnthracyclinesIBA 01/2018 - 01/2005
7	Epirubicin (Ellence)FDA LinkGeneric 03/2016 - 01/2010
5	human ERBB2 proteinIBA 10/2017 - 04/2010
5	Capecitabine (Xeloda)FDA Link 08/2013 - 04/2008
4	Bevacizumab (Avastin)FDA Link 01/2018 - 07/2013
4	Phenobarbital (Luminal)FDA Link 10/2017 - 05/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 07/2013
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2005
3	Tamoxifen FDA LinkGeneric 01/2008 - 10/2002
2	Carboplatin (JM8)FDA LinkGeneric 06/2014 - 09/2009
2	Vinorelbine (Navelbine)FDA LinkGeneric 08/2013 - 04/2008
2	Biomarkers (Surrogate Marker)IBA 05/2012 - 01/2008
1	cabazitaxel FDA Link 10/2017
1	130-nm albumin-bound paclitaxelIBA 03/2016
1	SolventsIBA 03/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	AfatinibIBA 07/2015
1	CreatinineIBA 07/2015
1	Lapatinib (GW572016)FDA Link 07/2015
1	pertuzumabIBA 07/2015
1	PlatinumIBA 06/2014
1	SaltsIBA 06/2014
1	Everolimus FDA Link 07/2013
1	Poly Adenosine Diphosphate RiboseIBA 06/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2011
1	Growth Factor ReceptorsIBA 01/2010
1	Fluorouracil (Carac)FDA LinkGeneric 01/2010
1	Methotrexate (Mexate)FDA LinkGeneric 01/2010
1	Estrogen ReceptorsIBA 07/2007
1	Anastrozole (Arimidex)FDA LinkGeneric 07/2007
1	Filgrastim (Neupogen)FDA Link 04/2005
1	Gefitinib (Iressa)FDA Link 01/2005
1	Tyrosine Kinase InhibitorsIBA 01/2005
1	Pharmaceutical PreparationsIBA 01/2005

Therapy/Procedure

27	Neoadjuvant Therapy 11/2019 - 10/2002
11	Drug Therapy (Chemotherapy) 01/2018 - 01/2008
5	Therapeutics 03/2016 - 04/2005
2	Mastectomy (Mammectomy) 11/2019 - 01/2010
1	Radiotherapy 11/2019
1	Adjuvant Chemotherapy 01/2011
1	Duration of Therapy 01/2010
1	Combination Drug Therapy (Combination Chemotherapy) 01/2010
1	Cytoreduction Surgical Procedures 09/2009
1	Aftercare (After-Treatment) 07/2007
1	Operative Surgical Procedures 11/2006
1	Segmental Mastectomy (Lumpectomy) 11/2006